iPD-L1-Vax

N/A

Report date: 2025/03/20 15:59:31

Base Information

Drug NameiPD-L1-Vax
Drug Alias Nameanti-PD-L1 dentritic cell therapy (Beijing Pomona Biological Technology)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Pomona Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Pomona Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A